All we know about polycythemia vera: literature review and own experience by K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Get full text

Dasatinib: ten years of clinical practice worldwide by K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Get full text

Primary myelofibrosis: own experience and news from diagnostic and treatment by K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Get full text

Primary myelofibrosis: own experience and news from diagnostic and treatment by K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Get full text

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission by V. A. Shuvaev, K. M. Abdulkadyrov, I. S. Martynkevich, M. S. Fominykh

Get full text

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission by V. A. Shuvaev, K. M. Abdulkadyrov, I. S. Martynkevich, M. S. Fominykh

Get full text

Combination therapy with ruxolitinib plus low-dose cytarabine or mercaptopurine in patients with blast-phase myelofibrosis by M. S. Fominykh, V. A. Shuvaev, I. S. Martynkevich, L. B. Polushkina, V. Yu. Udal’eva, K. M. Abdulkadyrov

Get full text

Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients by V. A. Shuvaev, M. S. Fominykh, I. S. Martynkevich, V. Y. Udaleva, N. A. Potikhonova, M. N. Zenina, K. M. Abdulkadyrov

Get full text

Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients by V. A. Shuvaev, M. S. Fominykh, I. S. Martynkevich, V. Y. Udaleva, N. A. Potikhonova, M. N. Zenina, K. M. Abdulkadyrov

Get full text

Complex karyotype is a marker of very poor prognosis in over 70-year-old patients with acute myeloid leukemia and extended types of myelodysplastic syndrome and high comorbidity in... by S V Gritsaev, I S Martynkevich, K M Abdulkadyrov, M P Ivanova, E V Petrova, I M Zapreeva, S A Tiranova, N A Potikhonova

Get full text

Aberrant methylation of the promoter regions of the SOX7 and p15INK4b genes and Wnt signaling pathway antagonists in patients with acute myeloid leukemias by I I Kostroma, S V Gritsaev, Zh Yu Sidorova, S A Tiranova, S P Svitina, Yu S Drizhun, Zh V Chubukina, I S Martynkevich, S I Kapustin, S S Bessmeltsev

Get full text

Cytogenetic profile in patients with primary myelodysplastic syndrome by S V Gritsaev, I S Martynkevich, E V Petrova, L S Martynenko, M P Ivanova, V Iu Aksenova, N Iu Tsybakova, N A Potikhonova, K M Abdulkadyrov

Get full text

PB1966: HEMOPOIETIC NICHE IMPAIRMENT IN TREATED MULTIPLE MYELOMA PATIENTS by N. Y. Semenova, N. I. Enukashvily, I. I. Kostorma, L. A. Belik, D. V. Baram, V. A. Balashova, S. V. Gritsaev, S. S. Bessmeltsev, D. I. Ostromyshenskii, I. S. Martynkevich

Get full text

Transformation of secondary myelodysplastic syndrome to atypical chronic myeloid leukemia in a female patient with acute myeloid leukemia by S V Gritsaev, I I Kostroma, I M Zapreev, A V Shmidt, S A Tiranova, V A Balashova, I S Martynkevich, Zh V Chubukina, N Yu Semenova, A V Chechetkin

Get full text

The specific features of diagnosis of mixed-phenotype acute leukemia: A combination of B-cell antigen expressions according to the results of flow cytometry and morphological marke... by S V Gritsaev, I I Kostroma, G M Ryadnova, S A Tiranova, Zh V Chubukina, V A Balashova, M N Zenina, I S Martynkevich, N A Potikhonova, K M Abdulkadyrov

Get full text

The specific features of the immunophenotype of blast cells in patients with de novo normal karyotype acute myeloid leukemia and FLT3-ITD mutation by S V Gritsaev, I S Martynkevich, Zh V Chubukina, E V Petrova, I I Kostroma, M P Ivanova, L S Martynenko, N A Potikhonova, L N Bubnova, K M Abdulkadyrov

Get full text

The role of pomalidomide in treatment of relapse and refractory multiple myeloma by S. V. Voloshin, S. Yu. Linnikov, A. D. Garifullin, A. A. Kuzyaeva, A. V. Shmidt, A. Yu. Kuvshinov, A. N. Bogdanov, M. A. Mikhileva, I. S. Martynkevich, M. N. Zenina, S. V. Sidorkevich

Get full text

Using the Minor Variant Finder software to identify and quantify the allelic burden level of somatic mutations in oncohematologic diseases by T. N. Subbotina, I. E. Maslyukova, A. A. Faleeva, P. A. Nikolaeva, A. S. Khazieva, E. A. Dunaeva, K. O. Mironov, L. B. Polushkina, I. S. Martynkevich, S. V. Vereshchagina, B. V. Barankin

Get full text

THROMBOTIC AND BLEEDING RISK FACTORS IN ESSENTIAL THROMBOCYTHEMIA by A. A. Zhernyakova, I. S. Martynkevich, V. A. Shuvaev, L. B. Polushkina, M. S. Fominykh, V. Yu. Udal’eva, I. I. Zotova, D. I. Shiсhbabaeva, S. V. Voloshin, S. S. Бессмельцев, A. V. Chechetkin, K. M. Abdulkadyrov

Get full text

Comparative efficacy of acute lymphoblastic leukemia treatment of children in St.-Petersburg using two COALL-92 versions by E. G. Boychenko, E. M. Petrova, I. A. Garbuzova, E. A. Nikitina, L. M. Shchugareva, T. N. Kulakova, T. A. Makarova, M. B. Belogurova, G. G. Radulesku, T. D. Viktorovich, E. D. Chavpetsova, L. I. Shats, G. I. Uleyskaya, I. S. Martynkevich, E. E. Zueva

Get full text